Published in Best Pract Res Clin Rheumatol on April 01, 2012
Biosimilars in rheumatology: a view from Latin America. Clin Rheumatol (2012) 0.96
Anti-inflammatory effects of vitamin E on adjuvant-induced arthritis in rats. Inflammation (2015) 0.81
Retention rates of infliximab and tocilizumab during a 3-year period in a Brazilian hospital. Einstein (Sao Paulo) (2013) 0.80
Chronic oral or intraarticular administration of docosahexaenoic acid reduces nociception and knee edema and improves functional outcomes in a mouse model of Complete Freund's Adjuvant-induced knee arthritis. Arthritis Res Ther (2014) 0.78
Ultrasound and Doppler US in Evaluation of Superficial Soft-tissue Lesions. J Clin Imaging Sci (2014) 0.77
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum (1995) 26.94
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum (1984) 20.51
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum (2010) 18.82
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med (2000) 16.20
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum (2008) 13.08
Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis (2010) 10.97
Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum (2006) 10.39
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med (2000) 10.21
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum (2008) 9.94
Rheumatoid arthritis. Lancet (2010) 9.37
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum (2005) 8.47
Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol (2007) 8.47
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis (2009) 8.37
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet (2004) 7.90
COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum (2002) 5.57
Therapeutic strategies for rheumatoid arthritis. N Engl J Med (2004) 5.51
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis (2010) 5.24
New therapies for treatment of rheumatoid arthritis. Lancet (2007) 4.80
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis (2011) 4.15
Clinical history as a screening test for ankylosing spondylitis. JAMA (1977) 3.60
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet (2010) 3.58
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum (2008) 2.75
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum (2008) 2.71
Toward a better understanding of methotrexate. Arthritis Rheum (2004) 2.69
Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum (2006) 2.67
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.66
Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum (2010) 2.52
The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum (2009) 2.45
Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis (2007) 2.38
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis (2009) 2.22
Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis (2010) 2.04
Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.99
Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol (2009) 1.78
Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort. J Rheumatol (2007) 1.73
Cutting edge: A critical functional role for IL-23 in psoriasis. J Immunol (2010) 1.61
Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum (2008) 1.58
Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum (2008) 1.58
Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum (2009) 1.56
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis (2010) 1.55
Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis. Nat Rev Rheumatol (2010) 1.48
Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun (2008) 1.32
Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Ann Rheum Dis (2010) 1.29
The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther (2010) 1.26
Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review. Curr Rheumatol Rep (2008) 1.21
Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum (2001) 1.13
The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol (2008) 1.10
Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford) (2011) 0.99
Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol (2009) 0.96
Summary findings of a systematic review of the ultrasound assessment of synovitis. J Rheumatol (2007) 0.95
pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease. J Rheumatol (2010) 0.92
RAPID3-an index of physical function, pain, and global status as "vital signs" to improve care for people with chronic rheumatic diseases. Bull NYU Hosp Jt Dis (2009) 0.91
Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial. Ann Rheum Dis (2006) 0.89
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet (2011) 5.56
Patient participation in medical consultations: why some patients are more involved than others. Med Care (2005) 3.68
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet (2010) 3.58
Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum (2005) 2.76
Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components. Arthritis Rheum (2006) 2.75
The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet Disord (2006) 2.67
The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum (2013) 2.40
Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA (2007) 2.17
Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum (2013) 1.72
Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum (2007) 1.53
Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis (2006) 1.47
Suicidal ideation among adults with arthritis: prevalence and subgroups at highest risk. Data from the 2007-2008 National Health and Nutrition Examination Survey. Arthritis Care Res (Hoboken) (2011) 1.42
Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007. Ann Rheum Dis (2009) 1.36
Ethnic and socioeconomic disparities in health among patients with rheumatic disease. Curr Opin Rheumatol (2005) 1.34
Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A (2011) 1.33
Time perspective and socioeconomic status: a link to socioeconomic disparities in health? Soc Sci Med (2009) 1.27
Computer aided evaluation of ankylosing spondylitis using high-resolution CT. IEEE Trans Med Imaging (2008) 1.19
Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study. Arthritis Rheum (2012) 1.10
Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis. Arthritis Res Ther (2009) 1.08
Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5. J Rheumatol (2010) 1.05
Socioeconomic and ethnic differences in disease burden and disparities in physical function in older adults. Am J Public Health (2010) 0.99
Sleep disturbances in adults with arthritis: prevalence, mediators, and subgroups at greatest risk. Data from the 2007 National Health Interview Survey. Arthritis Care Res (Hoboken) (2011) 0.96
Estimating rare disease prevalence from administrative hospitalization databases. Epidemiology (2005) 0.95
Sex disparities in self-reported physical functioning: true differences, reporting bias, or incomplete adjustment for confounding? J Am Geriatr Soc (2010) 0.95
Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States. Arthritis Care Res (Hoboken) (2014) 0.94
Economic considerations of the treatment of ankylosing spondylitis. Am J Med Sci (2012) 0.93
Psychological correlates of self-reported disease activity in ankylosing spondylitis. J Rheumatol (2010) 0.92
Quantitative measurement of syndesmophyte volume and height in ankylosing spondylitis using CT. Ann Rheum Dis (2013) 0.92
The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis. Rheumatology (Oxford) (2011) 0.91
The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD). Ann Rheum Dis (2009) 0.90
Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus. Arthritis Rheum (2003) 0.88
Cervical vertebral squaring in patients without spondyloarthritis. J Rheumatol (2012) 0.88
A pilot study of yoga as self-care for arthritis in minority communities. Health Qual Life Outcomes (2013) 0.86
Improved precision of syndesmophyte measurement for the evaluation of ankylosing spondylitis using CT: a phantom and patient study. Phys Med Biol (2012) 0.85
Comparison of the construct validity and sensitivity to change of the visual analog scale and a modified rating scale as measures of patient global assessment in rheumatoid arthritis. J Rheumatol (2010) 0.85
Time perspective and smoking, obesity, and exercise in a community sample. Am J Health Behav (2013) 0.84
Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases. Arthritis Res Ther (2010) 0.83
Interpreting studies of cardiovascular mortality in rheumatoid arthritis: the importance of timing. Arthritis Rheum (2008) 0.81
Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients. Radiology (2010) 0.81
Validation of new biomarkers in systemic autoimmune diseases. Nat Rev Rheumatol (2011) 0.81
Prospects for disease modification in ankylosing spondylitis: do nonsteroidal antiinflammatory drugs do more than treat symptoms? Arthritis Rheum (2005) 0.80
Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus. Arthritis Rheum (2012) 0.80
Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation. Arthritis Rheumatol (2014) 0.80
Association of measured physical performance and demographic and health characteristics with self-reported physical function: implications for the interpretation of self-reported limitations. Health Qual Life Outcomes (2010) 0.80
Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis? Arthritis Care Res (Hoboken) (2012) 0.80
Rheumatology care, patient expectations, and the limits of time. Arthritis Rheum (2004) 0.80
Time perspective and exercise, obesity, and smoking: moderation of associations by age. Am J Health Promot (2013) 0.79
Validation of English and Spanish-language versions of a screening questionnaire for rheumatoid arthritis in an underserved community. J Rheumatol (2008) 0.79
Measurement and treatment of radiographic progression in ankylosing spondylitis: lessons learned from observational studies and clinical trials. Curr Opin Rheumatol (2014) 0.78
Trends in hospitalizations for Pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the US: 1996-2007. Arthritis Rheum (2010) 0.78
Medicare reimbursement and the use of biologic agents: incentives, access, the public good, and optimal care. Arthritis Care Res (Hoboken) (2010) 0.78
Syndesmophyte growth in ankylosing spondylitis. Curr Opin Rheumatol (2015) 0.77
High precision semi-automated vertebral height measurement using computed tomography: A phantom study. Conf Proc IEEE Eng Med Biol Soc (2012) 0.77
Ceiling effects and the Schober test. J Rheumatol (2003) 0.77
Estimating disease prevalence and incidence using administrative data: some assembly required. J Rheumatol (2013) 0.77
Rheumatoid arthritis: Guidelines for the management of RA: breadth versus depth. Nat Rev Rheumatol (2009) 0.77
Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative? Arthritis Care Res (Hoboken) (2013) 0.77
17 and 23: prime numbers for ankylosing spondylitis? Lancet (2013) 0.76
Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol (2006) 0.76
Linear measurement of polyps in CT colonography using level sets on 3D surfaces. Conf Proc IEEE Eng Med Biol Soc (2009) 0.75
Physical therapy and surgery. Am J Med Sci (2012) 0.75
Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication? Arthritis Rheum (2011) 0.75
High precision semiautomated computed tomography measurement of lumbar disk and vertebral heights. Med Phys (2013) 0.75
Measures of psychological distress in patients with arthritis: comment on the article by Fuller-Thomson and Shaked. Arthritis Care Res (Hoboken) (2010) 0.75
Precision of syndesmophyte volume measurement for ankylosing spondylitis: a phantom study using high resolution CT. Conf Proc IEEE Eng Med Biol Soc (2009) 0.75
Short-term perioperative all-cause mortality and cardiovascular events in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2013) 0.75
Autoimmune diseases: early diagnosis and new treatment strategies. Clin Chem (2012) 0.75